Thymic Epithelial Progenitor Culture for In Vitro Maturation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to induce differentiation of thymic epithelial progenitors into mature thymic epithelial cells in vitro, necessitating grafting in a living body for differentiation.

Innovation Solution

A method involving culturing thymic epithelial progenitors for a prolonged period without retinoic acid and FGF-8, mimicking developmental signaling events to induce differentiation into mature thymic epithelial cells, using factors like RA at optimal concentrations to mimic the third pharyngeal pouch environment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If thymic epithelial progenitors are grafted in a living body to induce differentiation, then differentiation into mature thymic epithelial cells is achieved, but the process requires in vivo procedures which are complex and not suitable for routine production

Engineering Contradiction:
Improvedifferentiation efficiencyVSAvoidprocedure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces the mechanical/in vivo grafting procedure with an in vitro culture system. By establishing a defined culture medium containing specific growth factors (FGF-8, Activin A, and other components) that mimic the in vivo thymic microenvironment, the differentiation process is transferred from a surgical procedure to a controlled laboratory culture system, enabling routine production without requiring animal models or surgical interventions

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent optimizes culture parameters including the composition of the culture medium (specific growth factors and their concentrations), culture duration (3-6 weeks), temperature (37°C), and atmosphere (5% CO2) to achieve reliable differentiation. By carefully controlling these parameters, the system achieves consistent differentiation efficiency while maintaining a simple in vitro procedure

Inventive Principle:
Principle #35Parameter changes

2Reliability

If thymic epithelial progenitors are cultured in a three-dimensional environment to induce differentiation, then mature thymic epithelial cells are generated, but the culture system becomes complex and difficult to standardize

Engineering Contradiction:
Improvecell maturationVSAvoidculture system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts the essential signaling functions required for differentiation and incorporates them into a defined two-dimensional culture medium. By identifying and isolating the critical growth factors (FGF-8, Activin A, and other components) that mediate differentiation, the system achieves maturation without requiring complex three-dimensional structures, thereby simplifying the culture system while maintaining reliability

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent establishes optimal culture conditions including specific growth factor concentrations, culture duration (3-6 weeks), temperature (37°C), and atmosphere (5% CO2) to achieve reliable differentiation. By carefully controlling these parameters, the system achieves consistent maturation while maintaining a simple two-dimensional culture system that is easier to standardize and scale

Inventive Principle:
Principle #35Parameter changes

3Reliability

If factors such as RA, FGF-8, and Activin A are added to the culture medium to induce differentiation, then differentiation into thymic epithelial cells is enhanced, but the culture medium becomes more complex

Engineering Contradiction:
Improvedifferentiation inductionVSAvoidmedium composition complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent performs preliminary identification and characterization of the essential growth factors required for differentiation (FGF-8, Activin A, and other components). By determining which factors are necessary and at what concentrations, the system can create a defined medium that includes only these essential components, avoiding the need for numerous additional factors and simplifying the overall composition while maintaining high differentiation reliability

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20250332259A1Thymic epithelial cell production method
Publication Date: 2025.10.30 KYOTO UNIV
  • US20250332259A1 patent drawing
  • US20250332259A1 patent drawing
  • US20250332259A1 patent drawing

AI summary

The present invention provides a thymic epithelial cell production method, the method including a step for culturing thymic epithelial progenitor cells for a long period of time. The present invention also provides a transplant therapeutic agent that includes thymic epithelial cells produced by the production method according to the present invention. The present invention further provides a T cell production method, the method including a feature of causing thymic epithelial cells produced by the production method according to the present invention to contact hematopoietic stem cells or any cells in the process of differentiation from hematopoietic stem cells to T cells.